Dr. Loo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
875 Blake Wilbur Dr
Stanford Radiation Oncology
Stanford, CA 94305Phone+1 650-736-7143
Summary
- As the Director of Thoracic Radiation Oncology at Stanford, my clinical specialty is radiation therapy of lung and other thoracic cancers.
My clinical research focus is on clinical trials and clinical translation of advanced high-precision 4-D image-guided radiation therapy and stereotactic ablative radiotherapy (SABR), as well as novel indications of SABR such as severe pulmonary emphysema. I also conduct preclinical and translational research in novel functional and metabolic imaging and imaging biomarkers.
I co-lead a collaboration between the Department of Radiation Oncology and SLAC National Accelerator Laboratory to develop a next-generation ultra-rapid and precise medical linear accelerator system (PHASER), as well as a preclinical research program to study the radiobiology of ultra-rapid FLASH radiotherapy.
https://profiles.stanford.edu/Billy_Loo
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Radiation Oncology, 2001 - 2005
Kaiser Permanente Northern California (San Francisco)Internship, Internal Medicine, 2000 - 2001
University of California, Davis, School of MedicineClass of 2000, MD
University of California, San Francisco & BerkeleyPhD, Bioengineering, 2000
Certifications & Licensure
CA State Medical License 2001 - 2025- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Evaluation of Cyberknife Precision Radiation Delivery System for Unresectable Malignant Lung Cancer Start of enrollment: 2000 Mar 01
- Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic Correlation Start of enrollment: 2002 Nov 01
- Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers Start of enrollment: 1998 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 59 citationsGalectin-1 Mediates Radiation-Related Lymphopenia and Attenuates NSCLC Radiation ResponsePeiwen Kuo, Scott V. Bratman, David B. Shultz, Rie von Eyben, Cato Chan
Clinical Cancer Research. 2014-11-01 - 29 citationsNon-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in OncologyGregory J Riely, Douglas E Wood, David S Ettinger, Dara L Aisner, Wallace Akerley
Journal of the National Comprehensive Cancer Network. 2024-05-01 - 629 citationsNon-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.David S Ettinger, Douglas E Wood, Dara L Aisner, Wallace Akerley, Jessica R Bauman
Journal of the National Comprehensive Cancer Network. 2022-05-01
Press Mentions
Billy Loo: “FLASH” Radiation Therapy Brings Hope to Cancer PatientsMarch 5th, 2019- The Future of Fighting Cancer: Zapping Tumors in Less Than a SecondDecember 13th, 2019
Professional Memberships
- Member, Education Committee
- Member, Molecular Imaging
- International Association for the Study of Lung CancerMember, Publication Committee
- ASTRO State-of-the-Art Techniques SymposiumProgram Committee Co-Chair
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
